Vacuum therapy for erectile dysfunction that fails to respond to PDE-5i: report of 70 cases.
- Author:
Peng LI
1
;
Yi-Jun SHEN
;
Tie-Qun LIU
;
Meng MA
;
Shi-Jun ZHANG
;
Yi-Xin WANG
;
Ru-Hui TIAN
;
Hui-Xing CHEN
;
Ping PING
;
Xiang-Feng CHEN
;
Zheng LI
;
Zheng LI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Erectile Dysfunction; drug therapy; therapy; Humans; Male; Middle Aged; Penis; Phosphodiesterase 5 Inhibitors; therapeutic use; Treatment Failure; Treatment Outcome; Vacuum
- From: National Journal of Andrology 2013;19(3):236-240
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo assess the efficacy and safety of the Osbon ErecAid Vacuum Therapy System in the treatment of erectile dysfunction (ED) that fails to respond to PDE-5i.
METHODSThis study included 70 cases of ED not responding to the medication of PDE-5i. The patients were aged 25 -66 (38.9 +/- 9.1) years. Under our direction, the patients used the Osbon ErecAid Vacuum Therapy System for a month to increase blood oxygenation to the corpora cavernosa, and then employed the vacuum constriction device (VCD) to maintain penile erection for sexual intercourse. We compared their IIEF-5 scores and their and their partners' sexual satisfaction before and 3 months after treatment, and evaluated the safety and effect of the vacuum therapy.
RESULTSThe mean IIEF-5 scores of the patients were significantly increased from 10.2 +/- 4.0 before treatment to 13.3 +/- 4.7 at 3 months after the vacuum therapy (P < 0.05). The rate of therapeutic effectiveness was 77.1% (54/70), and the rates of sexual satisfaction of the patients and their partners were 64.3% (45/70) and 65.7% (46/70),
CONCLUSIONVacuum therapy for ED that does not respond to PDE-5i can significantly improve the patients' erectile function as well as their and their partners'sexual satisfaction, and therefore deserves clinical application.